Bupropion Hydrochloride Extended-release Tablets (xl)

Bupropion Hydrochloride Extended-release Tablets (xl)
SPL v11
SPL
SPL Set ID 78d34aad-9d4f-48c4-91eb-536e31c6b6c9
Route
ORAL
Published
Effective Date 2023-09-20
Document Type 34391-3 HUMAN PRESCRIPTION DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
Bupropion (300 mg)
Inactive Ingredients
Hypromelloses Magnesium Stearate Methacrylic Acid Polyethylene Glycol, Unspecified Triethyl Citrate Povidone Ethylcelluloses Silicon Dioxide Butyl Alcohol Ferrosoferric Oxide Isopropyl Alcohol Propylene Glycol Shellac Ammonia

Identifiers & Packaging

Pill Appearance
Imprint: 353 Shape: round Color: yellow Size: 9 mm Size: 8 mm Score: 1
Marketing Status
ANDA Active Since 2018-08-02

Description

Manufactured by: Cadila Healthcare Ltd. India.


Medication Information

Description

Manufactured by: Cadila Healthcare Ltd. India.

Section 42231-1

Manufactured by:

Cadila Healthcare Ltd.

India.

Package Label.principal Display Panel

NDC 65841-780-05

Bupropion Hydrochloride Extended-release Tablets USP (XL), 300 mg

500 Tablets

Rx only

NDC 65841-836-05

Bupropion Hydrochloride Extended-release Tablets USP (XL), 150 mg

500 Tablets

Rx only


Structured Label Content

Section 42231-1 (42231-1)

Manufactured by:

Cadila Healthcare Ltd.

India.

Package Label.principal Display Panel (PACKAGE LABEL.PRINCIPAL DISPLAY PANEL)

NDC 65841-780-05

Bupropion Hydrochloride Extended-release Tablets USP (XL), 300 mg

500 Tablets

Rx only

NDC 65841-836-05

Bupropion Hydrochloride Extended-release Tablets USP (XL), 150 mg

500 Tablets

Rx only


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)